Huan Hoang

Array ( [id] => 3804087 [patent_doc_number] => 05830758 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-03 [patent_title] => 'Isolated V.beta. TCR antibodies' [patent_app_type] => 1 [patent_app_number] => 8/437353 [patent_app_country] => US [patent_app_date] => 1995-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 21 [patent_no_of_words] => 15726 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/830/05830758.pdf [firstpage_image] =>[orig_patent_app_number] => 437353 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3646532 [patent_doc_number] => 05637567 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-10 [patent_title] => 'Method for modifying, diagnosing, and screening for IGF-I sensitive cell barrier properties' [patent_app_type] => 1 [patent_app_number] => 8/437796 [patent_app_country] => US [patent_app_date] => 1995-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 10839 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/637/05637567.pdf [firstpage_image] =>[orig_patent_app_number] => 437796 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3623782 [patent_doc_number] => 05612312 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-18 [patent_title] => 'Method for treating insulin resistance with IGF-I' [patent_app_type] => 1 [patent_app_number] => 8/436633 [patent_app_country] => US [patent_app_date] => 1995-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 10696 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/612/05612312.pdf [firstpage_image] =>[orig_patent_app_number] => 436633 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4061941 [patent_doc_number] => 05866402 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-02 [patent_title] => 'Chimeric MCP and DAF proteins with cell surface localizing domain' [patent_app_type] => 1 [patent_app_number] => 8/435149 [patent_app_country] => US [patent_app_date] => 1995-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8282 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/866/05866402.pdf [firstpage_image] =>[orig_patent_app_number] => 435149 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3688725 [patent_doc_number] => 05663293 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-02 [patent_title] => 'ICAM-related protein' [patent_app_type] => 1 [patent_app_number] => 8/433010 [patent_app_country] => US [patent_app_date] => 1995-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 29 [patent_no_of_words] => 27018 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/663/05663293.pdf [firstpage_image] =>[orig_patent_app_number] => 433010 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4077259 [patent_doc_number] => 05965723 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-12 [patent_title] => 'DNA encoding epithelins' [patent_app_type] => 1 [patent_app_number] => 8/431333 [patent_app_country] => US [patent_app_date] => 1995-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 33 [patent_no_of_words] => 22628 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/965/05965723.pdf [firstpage_image] =>[orig_patent_app_number] => 431333 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3966186 [patent_doc_number] => 05885961 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-23 [patent_title] => 'Methods of using epithelins to modulate cell proliferation' [patent_app_type] => 1 [patent_app_number] => 8/429998 [patent_app_country] => US [patent_app_date] => 1995-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 38 [patent_no_of_words] => 15493 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/885/05885961.pdf [firstpage_image] =>[orig_patent_app_number] => 429998 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3690232 [patent_doc_number] => 05644030 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-01 [patent_title] => 'Gene and method for production of an IgA binding protein' [patent_app_type] => 1 [patent_app_number] => 8/430024 [patent_app_country] => US [patent_app_date] => 1995-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7435 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/644/05644030.pdf [firstpage_image] =>[orig_patent_app_number] => 430024 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4064035 [patent_doc_number] => 05866541 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-02 [patent_title] => 'Fibronection binding protein from Streptococcus dysgalactiae' [patent_app_type] => 1 [patent_app_number] => 8/428713 [patent_app_country] => US [patent_app_date] => 1995-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 6295 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 253 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/866/05866541.pdf [firstpage_image] =>[orig_patent_app_number] => 428713 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3769981 [patent_doc_number] => 05849699 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'Soluble molecule related to but distinct from ICAM-1' [patent_app_type] => 1 [patent_app_number] => 8/425989 [patent_app_country] => US [patent_app_date] => 1995-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 11 [patent_no_of_words] => 5819 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849699.pdf [firstpage_image] =>[orig_patent_app_number] => 425989 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3773344 [patent_doc_number] => 05817511 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-06 [patent_title] => 'Nucleotide sequence coding for variable regions of the .alpha. chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses' [patent_app_type] => 1 [patent_app_number] => 8/348572 [patent_app_country] => US [patent_app_date] => 1995-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 11701 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/817/05817511.pdf [firstpage_image] =>[orig_patent_app_number] => 348572 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3728232 [patent_doc_number] => 05700907 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-23 [patent_title] => 'Nucleotide sequences coding for variable regions of .beta. chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses' [patent_app_type] => 1 [patent_app_number] => 8/423383 [patent_app_country] => US [patent_app_date] => 1995-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 21 [patent_no_of_words] => 15709 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/700/05700907.pdf [firstpage_image] =>[orig_patent_app_number] => 423383 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3725991 [patent_doc_number] => 05670342 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-23 [patent_title] => 'NDF peptides' [patent_app_type] => 1 [patent_app_number] => 8/417640 [patent_app_country] => US [patent_app_date] => 1995-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 5836 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/670/05670342.pdf [firstpage_image] =>[orig_patent_app_number] => 417640 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4004137 [patent_doc_number] => 06004929 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-21 [patent_title] => 'Biologically active PDGF A-chain homodimers' [patent_app_type] => 1 [patent_app_number] => 8/412551 [patent_app_country] => US [patent_app_date] => 1995-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 11 [patent_no_of_words] => 15407 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/004/06004929.pdf [firstpage_image] =>[orig_patent_app_number] => 412551 [rel_patent_id] =>[rel_patent_doc_number] =>)